The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration

Biomaterials

Volumn 31, Issue 33, 2010, Pages 8674-8683

  Wang, Chau Zen ^a,b   Chen, Shih Mao ^a,b   Chen, Chung Hwan ^a,b   Wang, Chih Kuang ^b   Wang, Gwo Jaw ^a,b,c   Chang, Je Ken ^a,b,d   Ho, Mei Ling ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF VIRGINIA   (United States)

^d KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

Author keywords

Adipose derived stem cells; Alendronate; BMP2; Bone regeneration; Osteogenesis

Indexed keywords

ADIPOSE DERIVED STEM CELLS; ALENDRONATE; BMP2; BONE REGENERATION; OSTEOGENESIS;

BONE; CELL CULTURE; DEFECTS; MINERALOGY; OSTEOBLASTS; PHOSPHATASES; POLYMERASE CHAIN REACTION; POLYMETHYL METHACRYLATES; PROTEINS; SCAFFOLDS;

STEM CELLS;

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BETA TUBULIN; BONE MORPHOGENETIC PROTEIN 2;

ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE MATRIX; BONE MINERALIZATION; BONE RADIOGRAPHY; BONE REGENERATION; BONE REMODELING; CALVARIA; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; WESTERN BLOTTING;

ADIPOSE TISSUE; ALENDRONATE; ALKALINE PHOSPHATASE; ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CALCIFICATION, PHYSIOLOGIC; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOHISTOCHEMISTRY; IMPLANTS, EXPERIMENTAL; IN SITU HYBRIDIZATION, FLUORESCENCE; LACTIC ACID; MALE; OSTEOGENESIS; POLYGLYCOLIC ACID; RATS; RATS, SPRAGUE-DAWLEY; SKULL; STEM CELLS; WOUND HEALING;

RATTUS;

EID: 77957295515     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.07.096     Document Type: Article

References (42)

1. Morris C.D., Einhorn T.A. Bisphosphonates in orthopaedic surgery. J Bone Jt Surg Am 2005, 87:1609-1618.
2. Rodan G.A., Fleisch H.A. Bisphosphonates: mechanisms of action. J Clin Invest 1996, 97:2692-2696.
3. Dunford J.E., Thompson K., Coxon F.P., Luckman S.P., Hahn F.M., Poulter C.D., et al. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 2001, 296:235-242.
4. Duque G., Rivas D. Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells. J Bone Miner Res 2007, 22:1603-1611.
5. von Knoch F., Jaquiery C., Kowalsky M., Schaeren S., Alabre C., Martin I., et al. Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterials 2005, 26:6941-6949.
6. Im G.I., Qureshi S.A., Kenney J., Rubash H.E., Shanbhag A.S. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004, 25:4105-4115.
7. Kenley R.A., Yim K., Abrams J., Ron E., Turek T., Marden L.J., et al. Biotechnology and bone graft substitutes. Pharm Res 1993, 10:1393-1401.
8. Service R.F. Tissue engineers build new bone. Science 2000, 289:1498-1500.
9. Goldstein S.A., Moalli M.R. Current concepts in tissue engineering: cell, matrices, and genes. Curr Opin Orthop 2001, 12:424-427.
10. Chang J.K., Li C.J., Wu S.C., Yeh C.H., Chen C.H., Fu Y.C., et al. Effects of anti-inflammatory drugs on proliferation, cytotoxicity and osteogenesis in bone marrow mesenchymal stem cells. Biochem Pharmacol 2007, 74:1371-1382.
11. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
12. Grigoriadis A.E., Heersche J.N., Aubin J.E. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J Cell Biol 1988, 106:2139-2151.
13. Wakitani S., Saito T., Caplan A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 1995, 18:1417-1426.
14. Stenderup K., Justesen J., Clausen C., Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003, 33:919-926.
15. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.
16. Winter A., Breit S., Parsch D., Benz K., Steck E., Hauner H., et al. Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum 2003, 48:418-429.
17. Strem B.M., Hicok K.C., Zhu M., Wulur I., Alfonso Z., Schreiber R.E., et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005, 54:132-141.
18. Wu S.C., Chang J.K., Wang C.K., Wang G.J., Ho M.L. Enhancement of chondrogenesis of human adipose derived stem cells in a hyaluronan-enriched microenvironment. Biomaterials 2009.
19. Yoon E., Dhar S., Chun D.E., Gharibjanian N.A., Evans G.R. In vivo osteogenic potential of human adipose-derived stem cells/poly lactide-co-glycolic acid constructs for bone regeneration in a rat critical-sized calvarial defect model. Tissue Eng 2007, 13:619-627.
20. Bais M.V., Wigner N., Young M., Toholka R., Graves D.T., Morgan E.F., et al. BMP2 is essential for post natal osteogenesis but not for recruitment of osteogenic stem cells. Bone 2009, 45:254-266.
21. Lee J.H., Kim B.G., Ahn J.M., Park H.J., Park S.K., Yoo J.S., et al. Role of PI3K on the regulation of BMP2-induced beta-Catenin activation in human bone marrow stem cells. Bone 2010, 46(6):1522-1532.
22. Nie H., Ho M.L., Wang C.K., Wang C.H., Fu Y.C. BMP-2 plasmid loaded PLGA/HAp composite scaffolds for treatment of bone defects in nude mice. Biomaterials 2009, 30:892-901.
23. Wang C.K., Ho M.L., Wang G.J., Chang J.K., Chen C.H., Fu Y.C., et al. Controlled-release of rhBMP-2 carriers in the regeneration of osteonecrotic bone. Biomaterials 2009, 30:4178-4186.
24. Hollinger J.O., Battistone G.C. Biodegradable bone repair materials. Synthetic polymers and ceramics. Clin Orthop Relat Res 1986, 290-305.
25. Lin T.M., Tsai J.L., Lin S.D., Lai C.S., Chang C.C. Accelerated growth and prolonged lifespan of adipose tissue-derived human mesenchymal stem cells in a medium using reduced calcium and antioxidants. Stem Cells Dev 2005, 14:92-102.
26. Chen C.H., Ho M.L., Chang J.K., Hung S.H., Wang G.J. Green tea catechin enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int 2005, 16:2039-2045.
27. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
28. Morrison T.B., Weis J.J., Wittwer C.T. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 1998, 24:954-958. p.960, 962.
29. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
30. Yoon J.J., Song S.H., Lee D.S., Park T.G. Immobilization of cell adhesive RGD peptide onto the surface of highly porous biodegradable polymer scaffolds fabricated by a gas foaming/salt leaching method. Biomaterials 2004, 25:5613-5620.
31. Schmitz J.P., Hollinger J.O. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986, 299-308.
32. Cowan C.M., Shi Y.Y., Aalami O.O., Chou Y.F., Mari C., Thomas R., et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004, 22:560-567.
33. Ho M.L., Chen Y.H., Liao H.J., Chen C.H., Hung S.H., Lee M.J., et al. Simvastatin increases osteoblasts and osteogenic proteins in ovariectomized rats. Eur J Clin Invest 2009, 39:296-303.
34. Wang C.K., Ho M.L., Wang G.J., Chang J.K., Chen C.H., Fu Y.C., et al. Controlled-release of rhBMP-2 carriers in the regeneration of osteonecrotic bone. Biomaterials 2009.
35. Arena V., Pennacchia I., Carbone A., Capelli A. Fluorescent in situ hybridization for human epidermal growth factor receptor 2 assessment in breast cancer: is it applicable as a primary test?. J Clin Oncol 2009, 27:e8. author reply e9-10.
36. Hayashi K., Yamaguchi T., Yano S., Kanazawa I., Yamauchi M., Yamamoto M., et al. BMP/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosis. Biochem Biophys Res Commun 2009, 379:261-266.
37. Odvina C.V., Zerwekh J.E., Rao D.S., Maalouf N., Gottschalk F.A., Pak C.Y. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 2005, 90:1294-1301.
38. Iwata K., Li J., Follet H., Phipps R.J., Burr D.B. Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia. Bone 2006, 39:1053-1058.
39. Srisubut S., Teerakapong A., Vattraphodes T., Taweechaisupapong S. Effect of local delivery of alendronate on bone formation in bioactive glass grafting in rats. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 104:e11-6.
40. Omi H., Kusumi T., Kijima H., Toh S. Locally administered low-dose alendronate increases bone mineral density during distraction osteogenesis in a rabbit model. J Bone Jt Surg Br 2007, 89:984-988.
41. Abbaspour A., Takahashi M., Sairyo K., Takata S., Yukata K., Inui A., et al. Optimal increase in bone mass by continuous local infusion of alendronate during distraction osteogenesis in rabbits. Bone 2009, 44:917-923.
42. Castano-Izquierdo H., Alvarez-Barreto J., van den Dolder J., Jansen J.A., Mikos A.G., Sikavitsas V.I. Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. J Biomed Mater Res A 2007, 82:129-138.